Delivery Systems

WEDNESDAY, Feb. 14, 2024 (HealthDay News) -- Access disparities to burn centers persist, with lower access in the South and West and for those with lower income, according to a research letter published online Feb. 14 in JAMA Surgery.Dong Gi Hur, from the Stanford School of Medicine in California, and colleagues characterized access to American Burn Association (ABA)-verified and self-designated burn centers nationwide using 2019 Trauma Information Exchange Program data.The researchers found that the total burn incidence rate increased by 11 percent to 257.2 per 100,000 people from 2013 to 2019. There was an increase observed in the number of burn centers to 133 (66 ABA verified) in 2019. Overall, 68.8 and 81.6 percent of the population had 60-minute access to ABA-verified and all burn centers, respectively. The median beds-to-incidence ratio was 8.1, with the highest and lowest ratios seen in New England and in the South and West, respectively. Populations with versus without 60-minute-transport access to ABA-verified and all burn centers had higher median income ($31,732 versus $26,440 and $30,797 versus $26,029, respectively). The proportion of racial and ethnic groups in Census Block Groups with 60-minute transport access to ABA-verified burn centers was 40, 86, 74, 74, 56, and 64 percent for American Indian, Asian, Black, Hispanic, Native-Hawaiian, and White populations, respectively."In regions where geographic and market barriers prevent timely access, expanding telemedicine availability could increase initial assessment and resuscitation of burn injuries for more patients," the authors write.<a target="_blank" rel="noopener noreferrer" href="https://jamanetwork.com/journals/jamasurgery/article-abstract/2814983">Abstract/Full Text (subscription or payment may be required)</a>

Disparities seen in access to burn centers, with lower access in the South and West and for those with lower income

Study Looks at Access to U.S. Burn Centers Using 2019 Data

THURSDAY, Jan. 11, 2024 (HealthDay News) -- In 2021, 12.8 percent of unique prescribers in Medicare Part D prescribed topical antifungals, with about 6.5 million topical antifungal prescriptions filled, at a total cost of $231 million, according to research published in the Jan. 11 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.Kaitlin Benedict, M.P.H., from the CDC in Atlanta, and colleagues used 2021 Medicare Part D data to examine prescription volumes, rates, and costs for topical antifungals. The volumes of total prescriptions were compared between higher-volume (top 10 percent of prescribers by volume) and lower-volume prescribers.The researchers found that about 6.5 million topical antifungal prescriptions were filled during 2021 (134 prescriptions per 1,000 beneficiaries), at a total cost of $231 million. Overall, 12.8 percent of the 1,017,417 unique prescribers prescribed topical antifungals. The highest percentage of prescriptions was written by primary care physicians (40.0 percent), followed by nurse practitioners or physician assistants, dermatologists, and podiatrists (21.4, 17.6, and 14.1 percent, respectively). Of all prescriptions, 44.2 percent (2.9 million) were written by higher-volume prescribers."The substantial volume of topical antifungal and antifungal-corticosteroid prescriptions among Medicare Part D beneficiaries in the setting of emerging resistant infections underscores the need to evaluate current practices of topical antifungal use," the authors write.<a target="_blank" rel="noopener noreferrer" href="https://www.cdc.gov/mmwr/volumes/73/wr/mm7301a1.htm?s_cid=mm7301a1_w">Abstract/Full Text</a>

Top 10 percent of prescribers by volume prescribed 44.2 percent of all prescriptions for antifungals

Delivery Systems Condition Center

Featured in Delivery Systems

Delivery Systems News & Research